Matinas BioPharma Holdings, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit: ratio: %
Description: Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary: Matinas BioPharma Holdings, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
Matinas BioPharma Holdings, Inc. Return On Assets for the quarter ending September 30, 2024 was -94.3 %, a 62.8% decline year-over-year.
Matinas BioPharma Holdings, Inc. annual Return On Assets for 2023 was -72.2 %, a 72.3% decline from 2022.
Matinas BioPharma Holdings, Inc. annual Return On Assets for 2022 was -41.9 %, a 21.7% decline from 2021.
Matinas BioPharma Holdings, Inc. annual Return On Assets for 2021 was -34.4 %, a 18.4% decline from 2020.

Return On Assets, Annual (%)

Return On Assets, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
2023	-72.2	-30.3	-72.3%	Jan 1, 2023	Dec 31, 2023
2022	-41.9	-7.46	-21.7%	Jan 1, 2022	Dec 31, 2022
2021	-34.4	-5.35	-18.4%	Jan 1, 2021	Dec 31, 2021
2020	-29.1	+8.74	+23.1%	Jan 1, 2020	Dec 31, 2020
2019	-37.8	+53.2	+58.5%	Jan 1, 2019	Dec 31, 2019
2018	-91	-3.5	-4%	Jan 1, 2018	Dec 31, 2018
2017	-87.5	+3.39	+3.73%	Jan 1, 2017	Dec 31, 2017
2016	-90.9	+0.59	+0.65%	Jan 1, 2016	Dec 31, 2016
2015	-91.5	+66.7	+42.2%	Jan 1, 2015	Dec 31, 2015
2014	-158			Jan 1, 2014	Dec 31, 2014

Showing 1 to 10 of 10 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.